Clinical Trial: Allo HSCT Using RIC and PTCy for Hematological Diseases
Study Status: Completed
Recruit Status: RECRUITING
Condition: Acute Myelogenous Leukemia
Study Type: INTERVENTIONAL
Official Title: Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning (RIC) With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases
Brief Summary:
This is a Phase II study following subjects proceeding with our Institutional non-myeloablative cyclophosphamide/ fludarabine/total body irradiation (TBI) preparative regimen followed by a related, unrelated, or partially matched family donor stem cell infusion using post-transplant cyclophosphamide (PTCy), sirolimus and MMF GVHD prophylaxis.
Read more